Get Live Data

Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally
Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globallyView Video

Latest Share Chat

  2. Share Prices
  3. Syncona Share Price
  4. Syncona Share News
  5. IN BRIEF: Syncona investee Achilles Therapeutics files for US IPO

Pin to quick picksSyncona Share News (SYNC)

Syncona Information

Share Price Information for Syncona (SYNC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 110.00
Bid: 112.00
Ask: 113.00
Change: -2.40 (-2.14%)
Spread: 1.00 (0.893%)
Open: 112.20
High: 113.60
Low: 110.00
Prev. Close: 112.40
SYNC Live PriceLast checked at -
Syncona is an Investment Trust

To deliver superior long-term capital appreciation from investments in life science businesses, leading long-only and alternative investment funds and managed accounts across multiple asset classes.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IN BRIEF: Syncona investee Achilles Therapeutics files for US IPO

Tue, 02nd Mar 2021 13:45

Syncona Ltd - investor in life science companies - Portfolio firm Achilles Therapeutics PLC files with US Securities & Exchange Commission for a proposed initial public offering of American Depositary Shares. JP Morgan, BofA Securities and Piper Sandler are expected to be book-running managers for the IPO, with Chardan, Oppenheimer & Co and Kempen & Co as co-managers. Syncona says the number ADSs to be sold and the pricing have not yet been set. Achilles is a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumours.

Current stock price: 254.38 pence

Year-to-date change: down 2.5%

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
13 Jun 2019 09:32

Syncona Scraps Dividend To Focus On "Capital Intensive" Portfolio

(Alliance News) - Life sciences investor Syncona Ltd on Thursday reported a "strong" annual performance, with core life sciences firms doing well, while it is also to halt is paying a to

Read more
6 Jun 2019 16:11

UK Earnings, Trading Statements Calendar - Next 7 Days

Friday 7 June Seneca Global Income & Growth TrustFull Year ResultsMonday 10 traffic 11

Read more
4 Jun 2019 08:38

Syncona Appoints Investment Banker Melanie Gee As Chair Designate

LONDON (Alliance News) - Healthcare company Syncona Ltd on Tuesday said Melanie Gee will take over the chair of its board from Jeremy Tigue over the coming months in preparation for Tigue's at

Read more
20 May 2019 09:21

Syncona Establishes New Cell Therapy Firm With GBP35 Million Financing

LONDON (Alliance News) - Healthcare company Syncona Ltd said Monday it has established a new cell therapy company, Quell Therapeutics, with GBP35 million financing commitment.Syncona has -

Read more
20 May 2019 07:21

Syncona launches cell-therapy company to combat organ rejection

(Sharecast News) - Syncona confirmed on Monday that it has founded a new cell-therapy treatment company, pitching in with £34.0m to fund the new venture in exchange for a 69.3% stake.

Read more
7 May 2019 10:44

WINNERS & LOSERS SUMMARY: Domino's Pizza Warns Of International Loss

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.----------FTSE 100 - up 1.8%. The telecommunications firm said it

Read more
7 May 2019 09:39

Syncona "Encouraged" By Investee Prostate Cancer Imaging Test Results

LONDON (Alliance News) - Syncona Ltd on Tuesday said it was encouraged by portfolio firm Blue Earth Diagnostics prostate cancer imaging tests results.The healthcare company said that a on a

Read more
7 May 2019 07:56

Syncona's Blue Earth reports positive prostate study findings

(Sharecast News) - Syncona on Tuesday said its portfolio company Blue Earth Diagnostics had reported positive results from a study into prostate cancer diagnosis.

Read more
16 Apr 2019 08:08

Syncona puts £18m into Autolus Therapeutics' US IPO

(Sharecast News) - Healthcare investment company Syncona said on Tuesday that its portfolio company, Autolus Therapeutics, has confirmed the closing of its previously-announced underwritten public offering in the United States of 4,830,000 American depositary shares (ADS).

Read more
11 Apr 2019 09:05

Syncona Creates Retinal Gene Therapy Platform After Unit Merger (ALLISS)

LONDON (Alliance News) - Syncona Ltd on Thursday said that a merger between its two units Gyroscope Therapeutics and Orbit Biomedical created the first fully integrated retinal gene therapy will a

Read more
11 Apr 2019 08:33

Syncona confirms merger of its Gyroscope and Orbit businesses

(Sharecast News) - Healthcare investment company Syncona announced the merger of its companies Gyroscope Therapeutics - an ophthalmology company developing genetically defined therapies for retinal diseases - and specialist subretinal therapeutic medical device company Orbit Biomedical on Thursday.

Read more
14 Mar 2019 15:18

FTSE 250 movers: Cineworld has a blockbuster, Just Group withers away

(Sharecast News) - London's FTSE 250 was up 0.63% at 19,300.09 in afternoon trade on Friday, as Cineworld put in a blockbuster performance to send the index reeling upwards.

Read more
13 Mar 2019 09:01

Wellcome Trust To Sell Part Of Syncona Stake Via Placing (ALLISS)

LONDON (Alliance News) - The Wellcome Trust Ltd on Wednesday said it will sell a small percentage of its shareholding in Syncona Ltd by way of a placing.The placing is expected to include a

Read more
12 Mar 2019 09:06

Syncona To Reduce Fund Investments And Increase Weighting To Cash

LONDON (Alliance News) - Life sciences investor Syncona Ltd on Tuesday said it will significantly reduce its fund investments over the next three to six months as it works to simplify the of its a

Read more
12 Mar 2019 08:28

Syncona focuses short-term cash on more conservative investments

(Sharecast News) - Healthcare firm Syncona plans to focus its investment strategy more towards conservative investments like cash and bonds moving forward.

Read more
101112131415161718

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.